New structural data on nonhydrolytic antibody catalysts gained over the pas
t two years confirm that antibodies elicited against transition-state analo
gues function by differential stabilisation of the transition-state over th
e ground state through electrostatic, van der Waals, cation-pi and hydrogen
-bonding interactions. The lack of chemical catalysis correlates with the l
ow catalytic efficiency. Novel strategies that precisely position a key fun
ctional residue in the antibody catalyst combining site have therefore emer
ged, as demonstrated by crystallographic studies. Whereas antibodies with a
bulky residue at position H100c of hypervariable loop H3 adopt different c
avity shapes, other antibodies share a common deep combining site. This str
uctural restriction might reflect the use of similar hydrophobic haptens to
generate the antibody; novel hapten design or new immunisation strategies
may, in the future, lead to more structurally diversified active sites.